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Available online 4 February 2013Abstract Extracellular matrix (ECM) mediates interactions between integrin and growth factor receptor (GFR) or ion
channel. Although this crosstalk promotes integration of the downstream signal pathways and then regulates cellular function,
the effect of ECM on glucose transporter (GLUT) in stem cells has not been elucidated. Therefore, we examined the effect of
fibronectin on GLUT-1 expression, trafficking, and its related signal pathways in mouse embryonic stem cells (mESCs).
Fibronectin increased 2-deoxyglucose (DG) uptake and GLUT-1 protein expression that were blocked by transcription or
translation inhibitors. Integrin α5β1-bound fibronectin increased 2-DG uptake through cluster formation with vascular
endothelial growth factor receptor (VEGFR) 2, and then activated Ras and PI3K/Akt. In another pathway, integrin α5β1
displayed structural and functional interactions with calcium channels, and stimulated 2-DG uptake through calcium influx and
PKC activation. Akt and PKC-induced PPARγ phosphorylation enhanced the decreased expression of PPARγ protein, and
subsequently increased GLUT-1 protein synthesis and 2-DG uptake. Fibronectin stimulated TC10 activity and cytoskeleton
(F-actin) rearrangement, followed by GLUT-1 trafficking. In conclusion, integrin-bound fibronectin stimulates GLUT-1 synthesis
through VEGFR2/Ras/PI3K/Akt and calcium channel/Ca2+/PKC, which are merged at PPARγ and GLUT-1 trafficking through
TC10 and F-actin.
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http://dx.doi.org/10.1016/j.scr.2013.01.008tiation. The biological relevance of ECM/integrin interactions
in regulating cell functions and signaling has been document-
ed. Crosstalk of integrins with many growth factor receptors
(GFRs) and channel proteins has also been investigated
(Borges et al., 2000; Miyamoto et al., 1996; Moro et al.,
1998; Wu et al., 1998). This represents a functional model in
which the same ECM molecule imposes a specific biological
response by the juxtaposition of integrins, GFRs, or channel
proteins in a confined spatial context, thus rendering ECM
proteins a dynamic scaffold for short range paracrine or
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matrix protein that provides guidance cues for directional cell
migration during development and disease (Zou et al., 2012).
Genetic deletion of fibronectin leads to embryonic death that
has been attributed to the indispensible role of fibronectin in
developmental branching morphogenesis (George et al.,
1993). Moreover, fibronectin modulates the Na+/H+ exchang-
er, manipulating intracellular pH and then migration (Park
et al., 2012). However, fibronectin-dependent mechanisms
in glucose transporters remain largely unknown. The mecha-
nisms underlying the interaction between fibronectin and
glucose uptake in embryonic stem cells (ESCs) and its related
signal mechanisms need to be elucidated.
To date, 13 members of the mammalian facilitative
glucose transporter (GLUT) family have been identified
(Macheda et al., 2005). Among them, GLUT-1 is expressed
throughout preimplantation development from oocytes, and
increases in developing embryos from the two-cell stage to
the blastocyst stage (Morita et al., 1994). Also, GLUT-1
(GLUT-1 −/−) depleted ESCs are non-viable. Therefore,
GLUT-1 has been implicated as one of the efficient isoforms
to supply glucose to ESCs. It is generally thought that the
phosphoinosital-3-kinase (PI3K) pathway induces varying
degrees of glucose uptake and GLUT translocation (Farese,
2002; Navarrete Santos et al., 2004; Welsh et al., 2005).
However, the sufficiency of this pathway alone to promote
glucose uptake remains unproven. Peroxisome proliferator-
activated receptor-gamma (PPARγ) regulates glucose me-
tabolism by increasing glucose uptake through facilitative
glucose transporter proteins (Armoni et al., 2007). More
recently, it has been demonstrated that the administra-
tion of the synthetic PPARγ agonist, rosiglitazone, increases
glucose uptake in tumor cells (Feng et al., 2011) but reduces
glucose uptake in macrophages (Liang et al., 2007). While
the correlation between GLUT-1 and PPARγ under the in-
fluence of fibronectin is still unclear, GLUT-1 mediates
basal glucose transporter expression in ESCs. In addition, an
essential role for TC10 (a member of the Rho family of small
G proteins) in regulating actin structure and its dynamic
rearrangement had emerged from prior studies on the
process of GLUT-4 translocation (Khan and Pessin, 2002).
Therefore, TC10 also could be a good candidate involved in
fibronectin-induced glucose uptake pathways. This study
aimed to investigate the effect of fibronectin on GLUT-1
expression, trafficking, and its related signal pathways in
mouse embryonic stem cells (mESCs).Materials and methods
Materials
mESCs (ES-E14TG2a) were obtained from the American
Type Culture Collection (Manassas, VA, USA). Fetal bovine
serum (FBS) was purchased from Gibco (Rockville, MD, USA).
Fibronectin (from bovine plasma), laminin (from Engelbreth–
Holm–Swarmmurine sarcoma basementmembrane), collagen
type I (from rat tail), collagen IV (from Engelbreth–Holm–
Swarm murine sarcoma basement membrane), fibrinogen
(from bovine plasma), protease inhibitor cocktail, actino-
mycin D, cycloheximide, ethylene glycol tetraacetic acid
(EGTA), 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraaceticacid-acetoxymethyl ester (BAPTA/AM), nifedipine, SKF96365,
fluorescein isothiocynate (FITC)-anti-rabbit antibody, FITC-
anti-mouse antibody, and tetramethylrhodamine-5-(and 6)-
isothiocyanate (TRITC)-anti-rabbit antibody were purchased
from Sigma-Aldrich (St. Louis, MO, USA). Propidium iodide
(PI), 4′, 6-diamidino-2-phenylindole (DAPI), and latrunculin B
were obtained from Invitrogen (Carlsbad, CA, USA). LY294002,
Akt inhibitor, bisindolylmaleimide I, GW9662, and troglita-
zone were obtained from Calbiochem (La Jolla, CA, USA).
Leukemia inhibitory factor (LIF), vascular endothelial
growth factor receptor (VEGFR)2 tyrosine kinase inhibitor,
farnesylthiosalicyclic acid, primary antibodies against
GLUT-1, VEGFR2, p-VEGFR2, p-VEGFR1, p-endothelial growth
factor receptor (EGFR), integrin β1, Ras, Rap1, PI3K p85α,
p-Akt thr308, p-Akt ser473, L-type Ca2+ channel (LTCC),
protein kinase C (PKC), p-PKC, PPARα, PPARβ/δ, PPARγ,
TC10, cdc42, Rac1, RhoA, neural Wiskott–Aldrich syndrome
protein (N-WASP), Arp2/3, IgG, β-actin, and secondary anti-
bodies against horseradish peroxidase (HRP)-conjugated goat
anti-rabbit IgG, goat anti-mouse IgG, and rabbit anti-goat IgG
were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). F-actin and p-PPARγ were obtained from Abcam
(Cambridge, MA, USA). All other reagents were of the highest
purity commercially available.
mESC culture
Cells were maintained in Dulbecco's modified Eagle's medium
(DMEM; Gibco-BRL, Gaithersburg, MD, USA) supplemented
with 3.7 g/L sodium bicarbonate, 1% penicillin/streptomycin,
1.7 mM L-glutamine, 0.1 mM β-mercaptoethanol, 5 ng/mL
mouse LIF, and 15% FBS. Cells were cultured without a feeder
layer for 5 days on culture dishes in an incubator maintained
at 37 °C with 5% CO2. The medium was changed to serum-free
standard medium (5% serum replacement instead of 15% FBS)
for 24 h prior to experiment.
[3H]-2-Deoxyglucose (2-DG) uptake
2-DG uptake was examined by removing the culture medium
by aspiration and gently washing the cells twice with uptake
buffer [140 mM NaCl, 2 mM KCl, 1 mM KH2PO4, 10 mM MgCl2,
1 mM CaCl2, 5 mM glucose, 5 mM L-alanine, 5 mM indometh-
acin, and 10 mM HEPES/Tris, (pH 7.4)]. Cells were then
incubated in uptake buffer containing 1 μCi/mL 2-DG at
37 °C for 30 min. At the end of the incubation period, cells
were washed three times with ice-cold uptake buffer and
were digested in 1 mL 0.1% sodium dodecyl sulfate (SDS).
Intracellular 2-DG uptake was determined by taking 900 μL
of each sample and by determining the radioactivity using a
model LS 6500 liquid scintillation counter (Beckman In-
struments, Fullerton, CA, USA). The radioactivity counts in
each sample were then normalized to the protein level and
were corrected for the zero-time uptake per mg protein.
Real-time reverse transcriptase-polymerase chain
reaction (RT-PCR)
Total RNA was extracted from cells and real-time quantifi-
cation of RNA targets was then performed in a Rotor-Gene
6500 real-time thermal cycling system (Corbett Research,
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kit (Qiagen, Valencia, CA, USA). The reaction mixture (20 μL)
contained 200 ng of total RNA, 0.5 μM of each primer,
appropriate amounts of enzymes, and fluorescent dyes as
recommended by the supplier. The Rotor-Gene 6500 cycler
was programmed as follows: 30 min at 50 °C for reverse
transcription, 15 min at 95 °C for DNA polymerase activa-
tion, 15 s at 95 °C for denaturation, 50 cycles of 15 s at
94 °C, 30 s at 55 °C, 30 s at 72 °C. The data was collected
during the extension step (30 s at 72 °C). The PCR reaction
was followed by a melting cure analysis to verify the
specificity and identity of the RT-PCR products; this
analysis can distinguish specific PCR products from non-
specific PCR products resulting from primer-dimer forma-
tion. The temperature of PCR products was elevated from
65 °C to 99 °C at a rate of 1 °C/5 s, and the resulting data
were analyzed using the software provided by the manu-
facturer. PCR primers used in this study are shown in
Tables 1 and 2.Table 2 The primers of integrins used for PCR.



















Cells were fixed with 3.5% paraformaldehyde, 0.1% Triton
X-100, and 5% bovine serum albumin (BSA), and were then
treated with a 1:50 dilution of primary antibody against
target protein. Each sample was then incubated for 30 min
with a 1:100 dilution of FITC or TRITC-conjugated secondary
antibody, and during the last 15 min PI (10 μg/mL) or DAPITable 1 The primers of GLUTs used for PCR.




















































AGCAGCCGTCCGGATCTCTTGCTCGAAGTC(10 μg/mL) was added. Fluorescence images were visualized
with a FluoView×300 fluorescence microscope (Olympus,
Tokyo, Japan).Measurement of calcium influx
Changes in intracellular calcium concentrations were mon-
itored using Fluo-3-AM that had initially been dissolved in
dimethylsulfoxide (DMSO). Cells in 35 mm-diameter culture
dished were rinsed with a Bath Solution [140 mM NaCl, 5 mM
KCl, 1 mM CaCl2, 0.5 mM MgCl2, 10 mM glucose, 5.5 mM
HEPES (pH 7.4)] and were then incubated in a Bath Solution
containing 3 μM Fluo-3-AM for 40 min, rinsed, mounted on
a perfusion chamber, and scanned at 1 s intervals using
confocal microscopy FluoView×300 fluorescence micro-






























































































374 H.N. Suh, H.J. Han488 nm and the emitted light was observed at 515 nm.
All analyses of calcium influx were processed in a single
cell, and the results are expressed as the fluorescentintensity (F/F0%, arbitrary unit, where F is fluorescence
captured at a particular time and F0 is initial fluorescence
image captured).
Figure 2 Involvement of integrins. (A) Cells were treated with
fibronectin for 24 h and examined for integrin isotypes (α1~v,
β1, 3, 4, 5, 6, 8) mRNA expression levels using realtime RT-PCR.
(B) Cells were treated with integrin β1 neutralizing antibody
(1 μg/mL) or control antibody (IgG; 1 μg/mL) for 30 min prior to
treatment of fibronectin for 24 h and 2-DG uptake was assessed.
Data represent the mean±SE of four independent experiments
with triplicate dishes. *Pb0.05 vs. untreated; **Pb0.05 vs.
fibronectin.
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Cells were lysed in buffer A [137 mM NaCl, 8.1 mM Na2HPO4,
2.7 mM KCl, 1.5 mM KH2PO4, 2.5 mM EDTA, 1 mM dithio-
threitol, 0.1 mM phenylmethanesulfonylfluoride, 10 μg/mL
leupeptin (pH 7.5)]. Resuspended cells were then mechan-
ically lysed on ice by triturating with a 21.1-gauge needle.
The lysates were first centrifuged at 1000 ×g for 10 min at
4 °C. Cytosolic and total particulate fractions were then
prepared by centrifuging the supernatants at 100,000 ×g for
1 h at 4 °C. The supernatants (cytosolic fraction) were then
precipitated with acetone, incubated for 5 min on ice, and
centrifuged at 20,000 ×g for 20 min at 4 °C. Pellets were
resuspended in buffer A containing 1% (v/v) Triton X-100.
The particulate fractions containing the membrane fraction
were washed twice and resuspended in buffer A containing
1% (v/v) Triton X-100. Protein was then quantified using the
Bradford procedure.
Western blotting and immunoprecipitation
Proteins (20–40 μg) from cell homogenates were separated
using 6–15% SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred to polyvinylidene fluoride mem-
branes. Each membrane was washed with Tris-buffered
saline Tween-20 (TBST) [10 mM Tris–HCl (pH 7.6), 150 mM
NaCl, 0.05% Tween-20], blocked with 5% skim milk for 1 h,
and incubated with the appropriate primary antibody at
dilutions recommended by the supplier. Membranes were
washed in TBST and probed with HRP-conjugated goat
anti-rabbit, goat anti-mouse IgG, or rabbit anti-goat sec-
ondary antibody. For immunoprecipitation, cell lysates
were incubated with both target antibodies and protein
A/G-sepharose beads and then gently shaken for 12 h.
Double-strength SDS-PAGE sample buffer was added into
beads and incubated at 100 °C for 5 min to release the
protein and then immunoblotting was performed with target
antibodies. To elucidate the specific protein–protein binding,
IgG was used as a negative control. Bands were visualized with
an enhanced chemiluminescence kit (Amersham Pharmacia
Biotech; Buckinghamshire, UK) and were quantified with TINA
2.0 software.
Small interfering ribonucleic acid
(siRNA) transfection
Cells were grown until 75% of the plate surface was covered,
after which they were transfected for 24 h with either a
SMARTpool of siRNAs specific to Ras (cat# L-061372), PI3K
p85α (cat# L-041079), Akt (cat# L-040709), PKCα/β (cat#
L-040348), PPARγ (cat# L-040712), TC10 (cat# L-064086), or
non-targeting (Nt) siRNAs (cat# D-001206; as a negative
control) (Dharmacon, Lafayette, CO, USA) using DharmafectFigure 1 Effect of fibronectin on 2-DG uptake. (A, B) mESCs were treated with fibronectin, laminin, collagen I, collagen IV, or fibrinogen
(10 μg/mL) for 24 h, and GLUT-1 was detected by Western blot and 2-DG uptake was assessed as described in Materials and methods. Data
represents the mean±SE of two independent experiments with triplicate dishes. *Pb0.05 vs. untreated. (C) Cells were treated with
fibronectin for 24 h and were examined for GLUT isotypes (1–12) mRNA expression levels using realtime RT-PCR. (D, E) Cells were treated
with actinomycin D (transcription inhibitor; 10−7 M) or cycloheximide (translation inhibitor; 4×10−6 M) for 30 min prior to treatment of
fibronectin for 24 h, and GLUT-1 was detected by Western blot and 2-DG uptake was assessed. Data represent the mean±SE of three
independent experiments with triplicate dishes. *Pb0.05 vs. untreated; **Pb0.05 vs. fibronectin.
376 H.N. Suh, H.J. Hantransfection reagent (Dharmacon). After 24 h, the transfec-
tion mixtures were replaced with regular medium and cells
were maintained in normal culture conditions (DMEM
supplemented with LIF and FBS) as they were prior to the
experiments. Efficiency of specific siRNA transfection used in
this studywas examined usingWestern blotting (Supplement 1).
Affinity precipitation of cellular GTP-Ras, Rap1, TC10,
Rac1, cdc42, and RhoA
Ras, Rap1, TC10, Rac1, cdc42, and RhoA activations were
determined using an affinity precipitation assay incorporat-
ing the glutathione-S-transferase (GST)-tagged fusion pro-
tein, corresponding to the human Ras Binding Domain (RBD,
residues 1–149) of Raf-1, residues 788–884 of human Ral
GDS-Rap Binding Domain (RBD), p21-binding domain (PBD,
residues 67–150) of human PAK-1, residues 7–89 of mouse
Rhotekin Rho Binding Domain (Millipore, Billerica, MA, USA),
which binds only to the active GTP-bound form. Cells that
had reached 70% confluence were incubated in the presence
of fibronectin for 30 min at 37 °C before the addition of lysis
buffer (25 mM HEPES, [pH 7.5], 150 mM NaCl, 1% Igepal
CA-630, 10 mM MgCl2, 1 mM EDTA, 10% glycerol, 1 μg/mL
aprotinin, 10 μg/mL leupeptin, and 1 mM Na3VO4) at 4 °C.
Whole cell lysates were then incubated with agarose-
conjugated GST-RBD 20 μg for 45 min at 4 °C, and were
then washed three times with lysis buffer. Agarose beads
were boiled in sample buffer to release active Ras, Rap1,
TC10, Rac1, cdc42, RhoA. Sample proteins were resolved by
15% SDS-PAGE followed by immunoblotting.
Duolink® fluorescence assay (proximity
ligation assay)
Integrin β1/VEGFR2 or integrin β1/LTCC interactions were
detected in situ using Duolink II secondary antibodies and
detection kits (Olink Bioscience, Uppsala, Sweden; Cat#.
92001, 92005, and 92007) according to the manufacturer's
instructions. Briefly, primary antibody against integrin β1Figure 3 Involvement of VEGFR2, Ras, and PI3K/Akt. (A) Cells were
prior to treatment of fibronectin for 1 h, and the expression of p-EGFR,
panel depicts the mean±SE of three independent experiments for eac
*Pb0.05 vs. p-EGFR untreated; **Pb0.05 vs. p-EGFR fibronectin; #Pb
(B) Cells were treated with AG1478 [EGFR tyrosine kinase (TK) inhibito
with integrinβ1 neutralizing antibody for 30 min prior to treatment of
the mean±SE of four independent experiments with triplicate dishe
VEGFR2 TK inhibitor. (C) Cells were treated with fibronectin for 24 h a
protein lysates were immunoprecipitated with an anti-integrin β1 an
example shown is representative of three independent experiments
fluorescence (integrin β1/VEGFR2 interaction; green dot) and PI (re
independent experiments. (E) Cells were treated with VEGFR2 TK in
loaded with affinity precipitation in the presence of 10 μg of GST on g
the proteins bound to the beads were separated by 15% SDS-PAGE, and
with farnesylthiosalicyclic acid (Ras inhibitor; 2.5×10−5 M) for 30 min
p85α, p-Akt thr308, and p-Akt ser473 were detected by Western blot. The
for each condition, as determined from densitometry relative toβ-actin. *
vs. p-Akt thr308 untreated; ##Pb0.05 vs. p-Akt thr308 fibronectin; &
fibronectin.(anti-rabbit) and VEGFR2 and LTCC (anti-mouse) were applied
under standard conditions. Duolink secondary antibody
against the particular primary antibody was then added.
These secondary antibodies were provided as conjugates to
oligonucleotides that were ligated together in a closed circle
by Duolink ligation solution if the antibodies were in close
proximity (b40 nm). Finally, polymerase was added, which
amplified any existing closed circles, and detection was
achieved with complementary, fluorescently labeled oligonu-
cleotides (green dot). PI staining (red) was used to verify cell
morphology and confocal images were acquired.Differential ultracentrifugation for ratios of
filamentous- and globular-actin
(F-actin/G-actin assay)
The protocol was according to manufacturer's instructions
(Cytoskeleton, Denver, CO, USA) with some modifications.
Cells were lysed in lysis buffer (37 °C); 50 mM PIPES
(pH 6.9), 50 mM NaCl, 5 mM MgCl2, 5 mM EGTA, 5% (vol/vol)
glycerol, 0.1% NP-40, 0.1% Triton X-100, 0.1% Tween 20, 0.1%
2-mercapto-ethanol, 0.001% antifoam C with 100 mM ATP
and a cocktail of protease inhibitors; and 0.4 mM tosyl
arginine methyl ester, 1.5 mM leupeptin, 1 mM pepstatin A,
and 1 M benzamidine (Cytoskeleton). Cell lysates were
placed on ice until all samples are dissolved and then
incubated at 37 °C for 10 min and then were transferred to
a prewarmed (37 °C) ultracentrifuge and spun at 150,000 ×g
for 1 h at 37 °C to separate the globular (G)-actin (superna-
tant) and filamentous (F)-actin fractions (Beckman, Fullerton,
CA, USA). The pellets were resuspended with the same
amount of volume of ice-cooled distilled water containing
10 μM cytochalasin D. The pellets were dissolved by tritura-
tion with a pipette and left on ice for 1 h, vortexing every
15 min for 1 min to dissociate F-actin. Resuspended solutions
were centrifuged at 2300 ×g for 5 min at 4 °C. The second
supernatants (F-actin) were collected, and all samples were
diluted with appropriate loading buffer and then separated by
SDS-PAGE.treated with integrin β1 neutralizing antibody or IgG for 30 min
p-VEGFR2, or p-VEGFR1were detected byWestern blot. The lower
h condition, as determined from densitometry relative to β-actin.
0.05 vs. p-VEGFR2 untreated; ##Pb0.05 vs. p-VEGFR2 fibronectin.
r; 10−5 M], VEGFR2 TK inhibitor (10−5 M) alone or in combination
fibronectin for 24 h, and 2-DG uptakewas assessed. Data represent
s. *Pb0.05 vs. untreated; **Pb0.05 vs. fibronectin; #Pb0.05 vs.
nd the plasmamembrane fraction was isolated. Plasmamembrane
tibody and blotted with antibody directed against VEGFR2. The
. (D) Cells were treated with fibronectin for 24 h and Duolink®
d) were assessed. The example shown is representative of four
hibitor for 30 min prior to fibronectin treatment, and were then
lutathione-sepharose beads. After each binding reaction at 4 °C,
were examined for GTP-bound Ras or Rap1. (F) Cells were treated
, prior to treatment of fibronectin for 1 h and expression of PI3K
lower panel depicts the mean±SE of four independent experiments
Pb0.05 vs. PI3K untreated; **Pb0.05 vs. PI3K fibronectin; #Pb0.05
Pb0.05 vs. p-Akt ser473 untreated; &&Pb0.05 vs. p-Akt ser473
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All results are expressed as mean±standard error (SE). All
experiments were analyzed by analysis of variance (ANOVA).
Several experiments were also evaluated by comparing the
treatment means to the control using a Bonferroni–Dunn
test. Statistical significance was defined at Pb0.05.Results
Effect of fibronectin on GLUT-1 expression and 2-DG
uptake
In experiments to elucidate whether ECM proteins are in-
volved in GLUT-1 expression and glucose uptake, fibronectin,
laminin, collagen I, and collagen IV significantly increased
GLUT-1 protein expression as well as glucose uptake, res-
pectively (Figs. 1A, B). Although the relationship between
fibronectin and other ECMs varied widely, we chose fibronec-
tin as a ligand for examining the influence of ECM on glucose
uptake, which is the most important in cell adhesion
(Ruoslahti, 1988; Zagris, 2001). Next, to determine which
GLUT isotype is involvedmainly in fibronectin-induced glucose
uptake, we analyzed the quantity of mRNA of each isotype
(GLUT-1–12). UntreatedmESCs expressed GLUT-1–8 (GLUT-1:
1, GLUT-2: 0.27, GLUT-3: 0.31, GLUT-4: 0.56, GLUT-5: 0.4,
GLUT-6: 0.14, GLUT-7: 0.26, GLUT-8: 0.39; relative to
untreated of GLUT-1) and among them, GLUT-1 was expressed
relatively higher than other isotypes. Also, fibronectin in-
creased GLUT-1, 4, 6, 8 (GLUT-1: 2.84, GLUT-4: 1.75, GLUT-6:
0.97, GLUT-8: 1; relative to untreated of GLUT-1) mRNA
expression level and GLUT-1was increased to the highest level
(Fig. 1C). Therefore, we selected GLUT-1 as a major glucose
transporter, which mediates glucose uptake in mESCs. Also,
fibronectin increased total GLUT-1 protein expression levels in
parallel with 2-DG uptake, which was blocked by transcription
(actinomycin D) or translation (cycloheximide) inhibitors
(Figs. 1D, E). The results indicated that fibronectin-induced
increase of glucose uptake is connected with increase of
GLUT-1 mRNA and protein expression levels.
Fibronectin-induced transactivation of VEGFR2 and
calcium channel
As fibronectin is able to bind to 12 separate integrins (Plow et
al., 2000), RT-PCR was used to examine the specific integrinFigure 4 Involvement of calcium channel and Ca2+/PKC. (A) Cells w
fraction was isolated. Plasma membrane protein lysates were im
blotted with antibody directed against LTCC. The example shown is r
treated with fibronectin for 24 h and Duolink® fluorescence (integr
The example shown is representative of three independent expe
antibody, EGTA (extracellular calcium chelator; 4×10−3 M) with
(L-type calcium channel blocker; 10−6 M), or SKF96365 (voltage-gate
for 30 min and loaded with 2 μM fluo-3-AM in serum free medium f
was measured. (D) Cells were treated with EGTA with BAPTA-AM, nife
for 30 min and expression of p-PKC was detected by Western blo
experiments for each condition, as determined from densitom
fibronectin; #Pb0.05 vs. nifedipine. (E) Cells were treated with SK
and immunofluorescence staining with PKC (green) or nucleus (PI; risotypes for fibronectin. Among the integrin α (α1~v) and β
isotypes (β1, β3, β4, β5, β6, β8), fibronectin significantly
increased integrin α5, α6, β1, β4, and β8 mRNA expression
levels, and augmented the integrin α5β1 mRNA expression
level most intensively (Fig. 2A), demonstrating that integrin
α5β1 is the major receptor for fibronectin. In addition,
inhibition of integrin β1 partially blocked fibronectin-
induced 2-DG uptake (Fig. 2B), which raised the possibility
that other receptors can induce glucose uptake.
As integrin may be related to GFRs, we examined the
relation between integrin β1 and GFRs in 2-DG uptake.
Fibronectin phosphorylated both EGFR and VEGFR2, but not
VEGFR1, and phosphorylation was blocked by integrin β1
neutralization (Fig. 3A). However, inhibition of EGFR (AG1478)
did not block glucose uptake, whereas inhibition of VEGFR2
and integrin β1 neutralization blocked glucose uptake
(Fig. 3B). Next, the structural interaction of integrin β1 and
VEGFR2 was detected using immunoprecipitation and proxim-
ity ligation assay. More VEGFR2 was immunoprecipitated with
integrin β1 in the presence of fibronectin (Fig. 3C) and
fibronectin increased integrin β1/VEGFR2 interaction (green
dot) (Fig. 3D). These results suggest that integrin β1 and
VEGFR2 have not only a functional relationship but also a
structural relationship. Because Ras GTPases are a VEGFR2
downstream signal molecule (Sase et al., 2009), we examined
the relationship between VEGFR2 and Ras GTPases. Fibronec-
tin increased Ras activation (GTP-bound form) that was
blocked by VEGFR2 tyrosine kinase inhibitor, but Rap1
activation was not changed (Fig. 3E). Because Ras and Rap1
have different downstream effector and intracellular locali-
zations (Zwartkruis and Bos, 1999), Ras might be a molecule
that is strongly phosphorylated by VEGFR2. Blockage of Ras
(farnesylthiosalicyclic acid) decreased PI3K activity and Akt
phosphorylation (Fig. 3F), suggesting that fibronectin stimu-
lates integrinβ1/VEGFR2 cluster formation, Ras, and PI3K/Akt
activation subsequently.
To examine the role of Ca2+/PKC in glucose uptake, we
measured the effect of fibronectin on calcium influx and PKC
activation. Fibronectin increased integrin β1/calcium chan-
nel protein complex formation (Fig. 4A) and integrin β1/
calcium channel interaction (green dot) (Fig. 4B). Fibronec-
tin also enhanced calcium influx, which was blocked by
integrin β1 neutralization. Moreover, blockage of voltage-
gated calcium channels (VOCs) with nifedipine partially
inhibited calcium influx, whereas blockage of both store-
operated calcium channels (SOCs) and VOCs with SKF96365
completely inhibited calcium influx (Fig. 4C). We examined
the involvement of PKC as a downstream effector moleculeere treated with fibronectin for 24 h and the plasma membrane
munoprecipitated with an anti-integrin β1 antibody and were
epresentative of three independent experiments. (B) Cells were
in β1/LTCC interaction; green dot) and PI (red) were assessed.
riments. (C) Cells were treated with integrin β1 neutralizing
BAPTA-AM (intracellular calcium chelator; 10−5 M), nifedipine
d calcium channel and stored-operated calcium channel; 10−5 M)
or 40 min and treated with fibronectin, and then calcium influx
dipine, or SKF96365 for 30 min prior to treatment of fibronectin
t. The lower panel depicts the mean±SE of four independent
etry relative to PKC. *Pb0.05 vs. untreated; **Pb0.05 vs.
F96365 for 30 min prior to treatment of fibronectin for 30 min
ed) were assessed.
379Fibronectin stimulates GLUT-1 synthesis and trafficking
380 H.N. Suh, H.J. Han
381Fibronectin stimulates GLUT-1 synthesis and traffickingon fibronectin-induced signaling. Fibronectin-increased PKC
phosphorylation and activation were blocked by SKF96365
(Figs. 4D, E).
Relationship between PPARγ and PI3K/Akt and
calcium/PKC in fibronectin-induced 2-DG uptake
The PPAR family of ligand-activated transcription factors
includes three PPAR isoforms (α, β/δ, and γ) that differ in
their tissue distribution, ligand specificity, and functions.
Among them, PPARγ plays a key role in glucose homeostasis
(Burns and Vanden Heuvel, 2007). Therefore, we examined
the involvement of PPAR signal pathways in fibronectin-
induced 2-DG uptake. Fibronectin decreased PPARγ expres-
sion in a time dependent manner, whereas PPARα or PPARβ/δ
expression was not changed (Fig. 5A). Moreover, GW9662
(PPARγ antagonist) increased GLUT-1 expression, while
troglitazone (PPARγ agonist) decreased GLUT-1 expression
(Fig. 5B), which supported a strong connection between
PPARγ and GLUT-1. 2-DG uptake results supported the
result that PPARγ specific siRNA with fibronectin increased
2-DG uptake to a higher degree than fibronectin alone
(Fig. 5C). Fibronectin also increased PPARγ phosphorylation
(Fig. 5D), which was mediated by Akt or PKC (Fig. 5E).
Fibronectin-induced 2-DG uptake was blocked by Ras, PI3K
p85α, Akt, and PKCα/β-specific siRNAs (Fig. 5F, G) as well as
chemical inhibitors (Supplement 2). These results suggested
that fibronectin-stimulated Ras, PI3K/Akt, and calcium/PKC
signaling merge at PPARγ, and then stimulate GLUT-1
synthesis and finally 2-DG uptake.
Involvement of TC10 and F-actin in
fibronectin-induced GLUT-1 trafficking
TC10 is a Rho family of small GTPase that regulates the
cytoskeleton (Kanzaki and Pessin, 2001). Therefore, we
examined the involvement of the Rho family in GLUT-1
trafficking through modulation of the cytoskeleton. Fibronec-
tin increased TC10, cdc42, and Rac1 activation in a time-Figure 5 Involvement of PPARγ on GLUT-1 synthesis. (A) Cells
expression of PPARα, PPARβ/δ, or PPARγ was detected by Western
experiments for each condition, as determined from densitometry r
treated with fibronectin, GW9662 (PPARγ antagonist; 10−5 M), or t
GLUT-1 was detected by Western blot. The lower panel depicts the m
determined from densitometry relative to β-actin. *Pb0.05 vs. unt
were transfected with PPARγ siRNA (20 μM) or non-targeting (Nt) siRN
2-DG uptake was assessed. Data represent the mean±SE of three
untreated; **Pb0.05 vs. fibronectin. (D) Cells were treated with fibro
was detected by Western blot. The lower panel depicts the mea
determined from densitometry relative to β-actin. *Pb0.05 vs. untr
bisindolylmaleimide I (PKC inhibitor; 10−6 M) for 30 min prior to
was detected by Western blot. The lower panel depicts the mea
determined from densitometry relative to β-actin. *Pb0.05 vs. u
bisindolylmaleimide I. (F) Cells were transfected with Ras siRNA (20
24 h prior to treatment of fibronectin for 24 h and 2-DG uptake wa
experiments with triplicate dishes. *Pb0.05 vs. untreated; **Pb0.05
(20 μM) or Nt siRNA for 24 h prior to treatment of fibronectin for 24 h
four independent experiments with triplicate dishes. *Pb0.05 vs. undependent manner. Among them, fibronectin enhanced TC10
activation the most, which depended on integrin β1 and
VEGFR2 (Figs. 6A, B). Also, depletion of TC10 decreased
GLUT-1 expression in the plasma membrane (Fig. 6C). To
elucidate the mechanism of trafficking induced by TC10, we
transfected TC10-specific siRNA and then examined F-actin
and its binding proteins (N-WASP, Arp2/3). Fibronectin in-
creased F-actin, N-WASP, and Arp2/3 expressions, which were
reversed by TC10 siRNA (Fig. 6D). To confirm the role of
F-actin rearrangement on GLUT-1 trafficking, latrunculin B
(inhibitor of actin polymerization) was applied as a pretreat-
ment. Latrunculin B reversed GLUT-1 protein expression levels
and intensity of green (F-actin) and red (GLUT-1) fluorescence
in the plasma membrane (Figs. 6E, F). Moreover, fibronectin
increased F-actin/G-actin ratios (Fig. 6G). As fibronectin
stimulated Ras, PI3K p85α, Akt, PKC, PPARγ, and TC10, we
examined whether other ECM components are involved in
these signal pathways. Laminin, collagen I, and collagen IV
activated Ras, PI3K p85α, Akt, PKC, PPARγ, and TC10, but not
fibrinogen (Supplement 3).Effect of fibronectin and its related signal pathways
on maintenance of pluripotency
In experiments to examine the role of fibronectin on mESC
stemness, fibronectin and its related signal pathways did not
affect mRNA expression of the markers of undifferentiation
(Oct4, Sox2) and differentiation [GATA4 (endoderm), Tbx5
(mesoderm), Fgf5 (ectoderm), Cdx2 (trophectoderm)], which
suggests that fibronectin induces maintenance of pluri-
potency. Fibronectin also increased cyclin D1 and cyclin E
protein expression levels, which were blocked by Ras, PI3K,
PKC, PPARγ, and TC10 siRNAs, respectively (Supplement 4).
These results demonstrated that fibronectin increased cell
proliferation of the pluripotent mESCs and Ras, PI3K, PKC,
PPARγ, and TC10 signal pathways are involved in cell pro-
liferation as well as glucose uptake. Taken together,
fibronectin-induced increase of glucose uptake might play an
essential role in maintenance of mESC stemness (Fig. 7).were treated with fibronectin for various times (0–24 h) and
blot. The lower panel depicts the mean±SE of four independent
elative to β-actin. *Pb0.05 vs. PPARγ untreated. (B) Cells were
roglitazone (PPARγ agonist; 10−5 M) for 24 h, and expression of
ean±SE of four independent experiments for each condition, as
reated; #Pb0.05 vs. untreated; ##Pb0.05 vs. GW9662. (C) Cells
A (20 μM) for 24 h prior to treatment of fibronectin for 24 h and
independent experiments with triplicate dishes. *Pb0.05 vs.
nectin for various times (0–24 h), and the expression of p-PPARγ
n±SE of four independent experiments for each condition, as
eated. (E) Cells were treated with Akt inhibitor (10−5 M) and/or
treatment of fibronectin for 24 h, and expression of p-PPARγ
n±SE of four independent experiments for each condition, as
ntreated; **Pb0.05 vs. fibronectin; #Pb0.05 vs. Akt inhibitor,
μM), PI3K p85α siRNA (20 μM), Akt siRNA (20 μM), or Nt siRNA for
s assessed. Data represent the mean±SE of three independent
vs. fibronectin. (G) Cells were transfected with PKCα/β siRNA
and 2-DG uptake was assessed. Data represent the mean±SE of
treated; **Pb0.05 vs. fibronectin.
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383Fibronectin stimulates GLUT-1 synthesis and traffickingDiscussionThe present data demonstrate that integrin-bound fibronec-
tin stimulates GLUT-1 synthesis through VEGFR2/Ras/PI3K/
Akt and calcium channel/Ca2+/PKC, which merge at PPARγ,
and GLUT-1 trafficking through TC10 and F-actin. A shortage
of fibronectin (FN−/−) induces abnormal embryonic devel-
opment, and finally, embryonic lethality (George et al.,
1993). Interestingly, during development, embryos produce
fibronectin in the cell itself (Shirai et al., 2005), demon-
strating the crucial role of fibronectin during embryogene-
sis. We found every ECM protein (fibronectin, laminin,
collagen I, collagen IV, fibrinogen) increased glucose uptake;
among them, fibronectin enhanced glucose uptake the most,
which was related with increased GLUT-1 mRNA and protein
expression level. In addition, the result shows that α5β1 is
a major integrin receptor for fibronectin in mESCs, but
that integrin β1 neutralization does not completely block
fibronectin-induced 2-DG uptake, raising the possibility that
fibronectin-bound integrin signaling is insufficient to increase
GLUT-1. Interactions between ECM proteins and growth
factors could enhance integrin-growth factor receptor cross-
talk and cellular response as well (Borges et al., 2000;
Miyamoto et al., 1996; Moro et al., 1998). Among them,
VEGF receptors are physically and functionally associatedwith
integrins (Ruoslahti, 2002). Immunoprecipitation and Duolink
assay data have provided strong evidence of the integrin
β1/VEGFR2 interaction. Presently, the inhibition of both
integrin β1 and VEGFR2 blocked 2-DG uptake. Abrogation of
fibronectin/integrin β1-induced transactivation of VEGFR by
disruption of the non-receptor tyrosine kinase Src, which
supports a mechanism in our model whereby Src and other
proteins associated with the actin cytoskeleton are required
for VEGFR transactivation in response to β1 integrin interac-
tion with fibronectin (Mahabeleshwar et al., 2006, 2007; Soldi
et al., 1999). But, such interactions were not experimentally
evident in our studies. Although integrin has the ability to
activate signal pathways independently (Assoian and Schwartz,
2001), our observation of cross talk between integrin β1 and
VEGFR2 provides strong evidence that a juxtamembraneFigure 6 Involvement of TC10 and cytoskeleton on GLUT-1 trafficking
andwere then loadedwith affinity precipitation in the presence of 10 μg
at 4 °C, the proteins bound to the beads were separated by 15% SDS-PA
RhoA. (B) Cells were treated with VEGFR2 TK inhibitor and/or integrin β
andwere then loadedwith affinity precipitation in the presence of 10 μg
at 4 °C, the proteins bound to the beads were separated by 15% SD
transfected with TC10 siRNA (20 μM) or Nt siRNA for 24 h prior to treat
membrane, and expression of GLUT-1was detected byWestern blot. The
for each condition, as determined from densitometry relative to β-acti
transfectedwith TC10 siRNA or Nt siRNA for 24 h prior to treatment of fib
detected by Western blot. The lower panel depicts the mean±SE of fou
densitometry relative toβ-actin. *Pb0.05 vs. N-WASP untreated; **Pb0.
vs. Arp2/3 fibronectin; &Pb0.05 vs. F-actin untreated; &&Pb0.05 vs. F-a
of actin polymerization; 10−5 M) for 30 min prior to treatment of fibrone
expression of GLUT-1 was detected by Western blot. The lower panel
condition as determined from densitometry relative to β-actin. *Pb0.05
latrunculin B for 30 min prior to treatment of fibronectin for 24 h, and i
nucleus (cyan) were assessed. (G) Cells were treated with fibronectin fo
measured by Western blot. The lower panel depicts the mean±SE of threceptor complex assembly promotes integration of the down-
stream signal pathways. Consistent with a previous study
(Rodriguez-Viciana et al., 1996), Ras and PI3K/Akt signaling
pathways converged in the cytoplasm. On the other hand, a
number of cytoplasmic signaling molecules are potential can-
didates to interact with the calcium channel (Wu et al., 1998).
Our results showed the engagement and clustering of integrin
β1 and LTCC by fibronectin, and that this interaction is
connectedwith calcium influx and PKC activation. Yanagida et
al. (2004) reported that calcium entry through the plasma
membrane is mainly mediated by SOCs, but not by VOCs, in
mESCs. However, we found that integrin-bound fibronectin
increased the intracellular calcium concentration, which is
mediated by calcium entry across the plasma membrane from
the outside of the cell, through the release of intracellular
VOC and calcium stored through SOC. The signaling mecha-
nism between the integrin and the calcium channel might
occur through a membrane-delimited pathway.
PPARγ plays a critical role in glucose metabolism and
homeostasis (Burns and Vanden Heuvel, 2007). However, the
precise molecular mechanisms are still unclear, although
previous reports have shown that activation of PPARγ may
enhance basal glucose uptake in 3T3-L1 adipocytes (Nugent et
al., 2001). Our results support the view that PPARγ phosphor-
ylation is mediated by both Akt and PKC, which show that
fibronectin-induced activation of Akt and PKC are merged
at PPARγ, assuming that PPARγ is able to regulate glucose
transporters. PPARγ specific antagonist (GW9662) and PPARγ
specific siRNA with fibronectin increased GLUT-1 protein
expression or 2-DG uptake, which provides strong support for
PPARγmediation of GLUT-1 synthesis. PPARγ is phosphorylat-
ed by activators (Adams et al., 1997; Akahoshi et al., 2003; Hu
et al., 1996; Lazennec et al., 2000; Sotiropoulos et al., 2006),
which decreases the transcriptional activity of PPARγ. Also,
both PPARγ1 and PPARγ2 repress GLUT transcription via
the direct binding of the heterodimer PPARγ/retinoid X
receptor-α to a GLUT promoter region, and detachment of
PPARγ from GLUT promoter leads to the alleviation of the
repression and then increase of GLUT expression (Armoni et
al., 2007). Therefore, PPARγ and GLUT have functional
interactions that occur in a reciprocally antagonistic manner.. (A) Cells were treated with fibronectin for various times (0–24 h)
of GST on glutathione-sepharose beads. After each binding reaction
GE and were then examined for GTP-bound TC10, cdc42, Rac1, or
1 neutralizing antibody for 30 min prior to treatment of fibronectin,
of GST on glutathione-sepharose beads. After each binding reaction
S-PAGE and were examined for GTP-bound TC10. (C) Cells were
ment of fibronectin for 24 h and were then separated into plasma
lower panel depicts themean±SE of four independent experiments
n. *Pb0.05 vs. untreated; **Pb0.05 vs. fibronectin. (D) Cells were
ronectin for 24 h and expression of N-WASP, Arp2/3, or F-actinwere
r independent experiments for each condition as determined from
05 vs. N-WASP fibronectin; #Pb0.05 vs. Arp2/3 untreated; ##Pb0.05
ctin fibronectin. (E) Cells were treated with latrunculin B (inhibitor
ctin for 24 h and were then separated into plasma membrane, and
depicts the mean±SE of three independent experiments for each
vs. untreated; **Pb0.05 vs. fibronectin. (F) Cells were treated with
mmunofluorescence staining with F-actin (green), GLUT-1 (red), or
r 24 h and then separated F-actin and G-actin, and F/G ratios were
ree independent experiments for each condition.
Figure 7 Hypothetical models of the signaling pathways underlying fibronectin-induced glucose uptake. Fibronectin-bound integrin
β1 enhances clustering with VEGFR2 and induces signaling Ras and PI3K/Akt. Also, integrin β1 forms a protein complex with LTCC and
stimulates calcium influx and PKC activation. Akt and PKC mediate PPARγ phosphorylation, decrease of PPARγ protein expression,
and increase of GLUT-1 protein synthesis subsequently. Activated TC10 regulates GLUT-1 trafficking through F-actin reorganization to
the plasma membrane. Finally, fibronectin-induced enhancement of GLUT-1 protein expression and trafficking was found to be
related to an increase of 2-DG uptake in mESCs.
384 H.N. Suh, H.J. HanAlso, we found that a fibronectin-induced increase of 2-DG
uptake was blocked by Ras, PI3K/Akt, and calcium/PKC
inhibition. Therefore, it is reasonable to expect that changes
in the ECM-integrin composition, and the consequent changes
in the signaling pathways downstream, including PPARγ ac-
tivation, underlie part of the altered GLUT-1 synthesis in
mESCs. However, further knowledge is required to fully un-
derstand the mechanisms of GLUT-1 regulation, which is
modified by PPARγ and others in elucidating themodulation of
mESCs functions by fibronectin.
Clostridium difficile toxin B, an inactivator of Rho GTPases,
inhibits GLUT translocation and glucose uptake (Khan and
Pessin, 2002), presumably GLUT translocation is mediated by
Rho GTPases. Presently, fibronectin increased TC10, Rac1, and
cdc42 activation, but the TC10 elevation was more intensively
affected by fibronectin than any other Rho family member.
Despite the similarity of TC10 to cdc42 and Rac1, it displays a
greater increase in GTPase activity over basal levels in the
presence of high GTPase activating protein (GAP) concentra-
tions (Neudauer et al., 1998). Therefore, TC10-GTP regulates
GLUT-1 trafficking to the plasma membrane. Activated small
G-proteins recruit the Arp2/3 complex via N-WASP to sites of
activated signaling complexes, thereby linking signaling to actin
dynamics (Machesky and Insall, 1999; Zigmond, 2000). Evidenceaccumulated to date indicates the involvement of N-WASP in
perinuclear actin rearrangement and GLUT-1 trafficking from
intracellular storage compartments to plasma membrane.
Our result showed that application of latrunculin B, an actin
monomer sequestering molecule, inhibited fibronectin-induced
glucose uptake and expression of both GLUT-1 and F-actin at
the plasma membrane. In the present study, the effect of
fibronectin on GLUT-1 expression was regulated by transcrip-
tional activity of PPARγ, and GLUT-1 trafficking was mediated
by cytoskeleton. Also, F-actin was revealed to be an effector
protein of TC10 or amodulator of GLUT-1 trafficking. Alongwith
our previous studies (Park et al., 2011, 2012), these results
demonstrate that fibronectin-induced 2-DG uptake contributes
to the maintenance of the pluripotency and renewal of mESCs.
This study highlights the substantial effects of fibronectin on
glucose transport, thereby providing a mechanistic basis for
distinct mESC functions that are observed when cells are
exposed to diverse matrix microenvironments. Here, we un-
covered a novel cross-talk between fibronectin and VEGFR or
calcium channel by identifying the transactivation of VEGFR as
well as calcium channel through PPARγ and TC10, which
regulates glucose uptake in mESCs.
Supplementary data to this article can be found online
at http://dx.doi.org/10.1016/j.scr.2013.01.008.
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